Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.790
-0.200 (-5.01%)
At close: Jul 21, 2025, 4:00 PM
3.740
-0.050 (-1.32%)
After-hours: Jul 21, 2025, 7:52 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $40.87 million as of July 21, 2025. Its market cap has decreased by -13.66% in one year.
Market Cap
40.87M
Enterprise Value
21.35M
1-Year Change
-13.66%
Ranking
Category
Stock Price
$3.79
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $40.87M, an increase of 34.77%. That is a compound annual growth rate of 6.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 43.03M | 25.08% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |